 Home > Active Ingredient News > Drugs Articles > Advancing the clinical research of iPSC therapy for Parkinson's disease, supported by ARCH, the company has raised nearly $150 million in Series B financing

Advancing the clinical research of iPSC therapy for Parkinson's disease, supported by ARCH, the company has raised nearly $150 million in Series B financing

 Last Update: 2022-08-15
 Source: Internet
 Author: User

Tags

what elavil used

new products development

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Biotech company Aspen Neuroscience announced the completion of a $145 million Series B financi.

The Series B financing will support planned studies of the company's lead product candidate for Parkinson's disease, ANPD001, including its patient screening cohort study and an upcoming Phase I/IIa clinical trial following an IND submission to the F.

Headquartered in San Diego, Aspen was founded in 2018 by a group of scientists in the lab of Jeanne Loring at the Scripps Research Institute and a group of patient organization advocates at the Summit for Stem Ce.

Aspen is developing and delivering iPSC-derived autologous cell replacement therapies for diseases of unmet medical need, starting with Parkinson's disea.

Parkinson's disease is the second most common neurodegenerative disease, affecting more than 10 million people worldwi.

Source: Aspen official website

Before the diagnosis of Parkinson's disease, about 50 percent of dopamine neurons in the substantia nigra are lo.

Stem cell-derived dopamine neurons are a personalized disease modification approach for restorative cell replacement thera.

Aspen's lead product (ANPD001) is currently undergoing an IND-enabling study for the treatment of sporadic Parkinson's disea.

Aspen Neuroscience is developing pipelin.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.